INSURADD vs GKSL: Stock Comparison
Head-to-head financial and trading comparison between INSURADD (INSURADD) and Gujarat Kidney And Super Speciality Limited (GKSL) in the Cross-Sector Peers sector.
INSURADD
NSE: INSURADDGKSL
NSE: GKSLKey Metrics Comparison Table
| Metric | INSURADD | GKSL | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹14.71 | ₹184.09 | — |
| 1-Year Price Return | +0.68% | +63.49% | GKSL (62.81% higher) |
| 52-Week High | ₹14.71 | ₹194.27 | — |
| 52-Week Low | ₹14.45 | ₹110.40 | — |
| 30-Day Annualized Volatility | 22.97% | 44.2% | INSURADD (Steadier) |
| 30-Day Average Daily Volume | 7,857,485 | 2,108,623 | INSURADD (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between INSURADD and GKSL, which stock gave better returns over the last year?
GKSL has outperformed INSURADD over the past 12 months with a gain of 63.49% compared to 0.68%.
Which stock is less volatile: INSURADD or GKSL?
INSURADD demonstrated lower price volatility (22.97% annualized) compared to GKSL (44.2%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of INSURADD vs GKSL?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are INSURADD and GKSL direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.